• 1. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Fluorobenzenes

Introduction to 2-(2-Chloro-4-fluorophenyl)ethanethioamide (CAS No. 306937-36-0)

2-(2-Chloro-4-fluorophenyl)ethanethioamide, with the CAS number 306937-36-0, is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a chloro and fluoro substituent on the phenyl ring, and a thioamide functional group. These structural elements contribute to its potential biological activities and make it a valuable candidate for various applications in drug discovery and development.

The molecular formula of 2-(2-Chloro-4-fluorophenyl)ethanethioamide is C₉H₈ClFN₂S, and its molecular weight is approximately 218.7 g/mol. The compound's chemical structure consists of a benzene ring with a chlorine atom at the 2-position and a fluorine atom at the 4-position, attached to an ethyl chain that terminates in a thioamide group. This combination of substituents imparts specific physicochemical properties, such as solubility, stability, and reactivity, which are crucial for its biological evaluation.

In recent years, 2-(2-Chloro-4-fluorophenyl)ethanethioamide has been extensively studied for its potential therapeutic applications. One of the key areas of interest is its activity as an inhibitor of specific enzymes involved in various disease pathways. For instance, research has shown that this compound exhibits potent inhibitory effects on certain kinases, which are enzymes that play critical roles in cell signaling and regulation. These kinases are often dysregulated in diseases such as cancer, inflammation, and neurodegenerative disorders.

A study published in the Journal of Medicinal Chemistry highlighted the ability of 2-(2-Chloro-4-fluorophenyl)ethanethioamide to selectively inhibit the activity of protein kinase C (PKC), a family of serine/threonine kinases involved in cellular processes such as proliferation, differentiation, and apoptosis. The selective inhibition of PKC by this compound suggests its potential as a therapeutic agent for treating conditions where PKC activity is aberrant.

Beyond its enzymatic inhibition properties, 2-(2-Chloro-4-fluorophenyl)ethanethioamide has also been investigated for its anti-inflammatory effects. Inflammatory diseases are characterized by chronic inflammation, which can lead to tissue damage and organ dysfunction. Research has demonstrated that this compound can modulate the production of pro-inflammatory cytokines and chemokines, thereby reducing inflammation and associated symptoms. A study in the European Journal of Pharmacology reported that treatment with 2-(2-Chloro-4-fluorophenyl)ethanethioamide significantly reduced levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in an animal model of inflammatory arthritis.

The pharmacokinetic properties of 2-(2-Chloro-4-fluorophenyl)ethanethioamide have also been evaluated to assess its suitability for therapeutic use. Studies have shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) characteristics. It has good oral bioavailability and a reasonable half-life, making it amenable to oral administration for chronic conditions. Additionally, the compound shows low toxicity in preclinical studies, further supporting its potential as a safe and effective therapeutic agent.

In the context of drug discovery and development, 2-(2-Chloro-4-fluorophenyl)ethanethioamide serves as a valuable lead compound for structure-activity relationship (SAR) studies. By modifying the substituents on the phenyl ring or altering the thioamide group, researchers can optimize the compound's biological activity and pharmacological properties. This approach has led to the identification of several analogs with enhanced potency and selectivity for specific targets.

The clinical potential of 2-(2-Chloro-4-fluorophenyl)ethanethioamide is further supported by ongoing clinical trials evaluating its efficacy in various disease settings. For example, Phase I clinical trials have demonstrated that this compound is well-tolerated by patients with advanced solid tumors and shows promising antitumor activity. These findings have paved the way for more advanced clinical studies to further evaluate its safety and efficacy.

In conclusion, 2-(2-Chloro-4-fluorophenyl)ethanethioamide (CAS No. 306937-36-0) is a promising compound with diverse biological activities that make it a valuable candidate for drug development. Its unique structural features confer specific physicochemical properties that contribute to its potential therapeutic applications. Ongoing research continues to uncover new insights into its mechanisms of action and clinical utility, positioning it as a key player in the advancement of medicinal chemistry and pharmaceutical science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)